AEGiS-APPJ: Regulatory Concerns Regarding AIDS Vaccine Development AIDS & Public Policy JournalImportant note: Information in this article was accurate in 1988. The state of the art may have changed since the publication date.
Click here to return to Associated Press main menu
DonateNow
Print this Article


Regulatory Concerns Regarding AIDS Vaccine Development

AIDS & Public Policy Journal 3, no. 3 (1988): 36-45
Leigh A. Sawyer, David A. Katzenstein, and Gerald V. Quinnan, Jr.

The pandemic of AIDS presents an unprecedented challenge to science and society. Current prevention and control strategies depend on testing, counseling and education, and screening of blood donors to protect the blood supply. However, these strategies will probably be insufficient to prevent the continued spread of the AIDS virus. A safe and effective vaccine may prove an essential part of programs to prevent human immunodeficiency virus (HIV) infection and AIDS. Here we discuss the regulatory and ethical concerns that surround the development and clinical testing of AIDS vaccines.
880915
APPJ883308

Copyright © 1988 - AIDS & Public PolicyJournal. Reproduction of this article (other than one copy for personal reference) must be cleared through the APPJ Permissions Desk.

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, Bridgestone/Firestone Charitable Trust, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1986, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .